New implant device remotely monitors heart failure patients at Northwestern Memorial

Aug 06, 2008

Chest pain and shortness of breath are common symptoms that send tens of thousands of heart failure (HF) patients into U.S. hospitals each month. Cardiologists at the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital may be able to curb such visits for some of their HF patients as they recently became Chicago's first researchers using a new wireless pressure sensor technology that allows them to track the pulmonary artery pressure of the subjects while these subjects remain at home.

"Some heart failure patients spend a lot of time in and out of the hospital due to chest pain and trouble breathing," says John B. O'Connell, MD, co-director of the Bluhm Cardiovascular Institute, director of its Center for Heart Failure and professor of medicine at Northwestern University's Feinberg School of Medicine. "At any time, such as when the subject is beginning to feel poorly, we immediately get readings of pulmonary pressure. We are hopeful we can avoid a hospitalization by adjusting the subject's medication based on the pressure recording. As we evaluate the CardioMEMS Wireless Pressure Monitoring System, we see great potential to increase convenience to patients and hospital efficiency by cutting back on frequent trips to the emergency room."

The implanted pressure sensor is about the size of a standard paperclip. It is implanted into the subject's pulmonary artery through a catheter-based procedure from the groin region. The technology that allows for subjects to get readings remotely from home is a proprietary electronic monitoring system that works when they lie on a pillow containing an antenna that interacts with the implanted device to get readings on heart and lung pressures. Northwestern Memorial has implanted three subjects to date and seven more are planned as part of the CHAMPION (CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Patients) clinical study.

As O'Connell explains, when your heart doesn't pump normally, adequate blood (oxygen and nutrients) may not reach your body tissues. When this occurs, the body believes that there is not enough fluid inside its vessels. The body's hormone and nervous systems try to make up for this (or compensate) by holding on to sodium and water in the body, and by increasing heart rate—all of which are symptoms often seen in HF patients, but in many cases, can be managed with medication. The back pressure in the lungs due to the inability of the heart to pump the blood effectively can be measured and transmitted by this device.

With this system, pressure data is transmitted to a secure database that makes the data available to physicians from a proprietary Web site. Data can also be made available to physicians on a handheld device, like a BlackBerry for instance.

Source: Northwestern Memorial Hospital

Explore further: Hormonal therapy for transsexualism safe and effective

add to favorites email to friend print save as pdf

Related Stories

Testing smart homes technology

Jun 11, 2013

A safer and healthier old age – that is the aim of GiraffPlus, an international project led by researchers at Örebro University, Sweden. With a focus of developing sophisticated aids for the elderly in ...

Engineers monitor heart with paper-thin flexible 'skin'

May 15, 2013

(Phys.org) —Engineers combine layers of flexible materials into pressure sensors to create a wearable heart monitor thinner than a dollar bill. The skin-like device could one day provide doctors with a ...

Wearable robots getting lighter, more portable

May 09, 2013

When Michael Gore stands, it's a triumph of science and engineering. Eleven years ago, Gore was paralyzed from the waist down in a workplace accident, yet he rises from his wheelchair and walks across the ...

Physical by smartphone becoming real possibility

May 03, 2013

It's not a "Star Trek" tricorder, but by hooking a variety of gadgets onto a smartphone you could almost get a complete physical - without the paper gown or even a visit to the doctor's office.

Recommended for you

Hormonal therapy for transsexualism safe and effective

10 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

14 hours ago

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments : 0

More news stories

3D printing tiny batteries

(Phys.org) —3D printing can now be used to print lithium-ion microbatteries the size of a grain of sand. The printed microbatteries could supply electricity to tiny devices in fields from medicine to communications, ...